walvax biotechnology co-a
Transactions by WALVAX BIOTECHNOLOGY CO-A (300142) in the last 6 months
Walvax Biotechnology Co.,Ltd (SZSE:300142) signed a cooperative agreement to acquire 21% stake in Guangdong Wellen Biological Pharmaceutical Co., Ltd. from Guizhou-based biotechnology company and Shantou-based industry company on December 6, 2014.
Walvax Biotechnology Co.,Ltd (SZSE:300142) agreed to acquire Chongqing Beining Biological Pharmaceutical Co., Ltd. from Shihezi Longchen Investment Partnership (Limited Partnership) and Yuan Yong for CNY 350 million on November 12, 2014. Under the terms of the deal, Walvax Biotechnology Co.,Ltd will pay CNY 178.5 million to Shihezi Longchen Investment Partnership for 51% stake and CNY 171.5 million to Yuan Yong for 49% stake in Chongqing Beining Biological Pharmaceutical ...
Du Jiangtao signed a share transfer agreement to acquire 46% stake in Hebei Da'an Pharmaceutical Co., Ltd. from Walvax Biotechnology Co.,Ltd (SZSE:300142) for approximately CNY 630 million on October 9, 2014. The transaction was approved by Board of Directors and shareholders of Walvax Biotechnology approved the transaction on October 27, 2014.
Walvax Biotechnology Co.,Ltd (SZSE:300142) signed a share transfer agreement to acquire Beijing Rui'ermeng Biotechnology Development Co., Ltd. from Li Yonggang for CNY 5 million on August 22, 2014. Walvax Biotechnology Co.,Ltd will use its own funds for the acquisition. As of December 31, 2013, Beijing Rui'ermeng Biotechnology Development Co., Ltd. had total assets of CNY 6.45 million, shareholders liability of CNY 0.9 million, revenue of CNY 1.55 million, and net loss ...
|No competitor information is available for 300142.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|